Human hepatic metabolism of a novel 2-carboxyindole glycine antagonist for stroke: in vitro-in vivo correlations

References

• BORDI, F., PIETRA, C., ZIVIANI, L. and REGGIANI, A., 1997, The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal is chemia in the rat. Experimental Neurology, 145, 425–433.
   PubMed Web of Science ®Google Scholar
• BRADFORD, M., 1976, A rapid and sensitive method for the quantitation of microgram of quantity of protein utilizing the principle of dye binding. Analytical Biochemistry, 72, 248–254.
   PubMed Web of Science ®Google Scholar
• CHIAMULERA, C., COSTA, S. and REGGIANI, A., 1990, Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning. Psychopharmacology,, 102, 551.
   PubMed Web of Science ®Google Scholar
• COLLINRIDGE, G. L. and BLISS, T. V. P., 1987, NMDA receptors — their role in long term potentiation. Trends Neuroscknces, 10, 288–293.
   Google Scholar
• COLLINRIDGE, G. L. and WATKINS, J. C., 1994, The NMDA Receptor, 2nd edn (Oxford: Oxford University Press).
   Google Scholar
• EBNER, T. and BURCHELL, B., 1993, Substrate specificities of two stably expressed human liver UDP - glucuronosyl transferases of the UGT1 gene family. Drug Metabolism and Disposition, 21,50–55.
   PubMed Web of Science ®Google Scholar
• GAVIRAGHI, G., DI FABIO, R., CUGOLA, A., DONATI, D., FERIANI, E., TRIST, D. G. and REGGIANI, A., 1996, Novel glycine antagonists as potent neuroprotective agents. Pharmacochemistry Library, 28, 81–95.
   Google Scholar
• GOLDSTEIN, J. A. and DE MORAIS, S. M. F., 1994, Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacokinetics, 4, 285–299.
   Google Scholar
• GORROD, J. W., TEMPLE, D. J. and BECKETT, A., 1975, The metabolism of N-ethyl-N-methylaniline by rabbit liver microsomes: the measurement of metabolites by gas—liquid chromatography. Xenobiotica, 5, 453–462.
   PubMed Web of Science ®Google Scholar
• HOKE, J. F., DYKER, A. G., MCALLISTER, A. M. and LEES, K. R., 1998, Pharmacokinetics of GV150526 following multiple intravenous doses in acute stroke patients. Abstract, 6th European Stroke Conference, Amsterdam, The Netherlands.
   Google Scholar
• HOUSTON, J. B. and CARLILE, D. J., 1997, Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices. Drug Metabolism Reviews, 29, 891–922.
   PubMed Web of Science ®Google Scholar
• IWATSUBO, T., HIROTA, T., 00IE, T., SUZUKI, H., SHIMADA, H., CHIBA, K., ISHIZAKI, T., GREEN, C. E., TYSON, C. A. and SUGIYAMA, Y., 1997, Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacology and Therapeutics, 73, 147–171.
   Google Scholar
• IYER, K. R. and SINZ, M. W., 1999, Characterisation of Phase I and Phase II hepatic drug metabolism activities in a panel of human liver preparations. Chemico-Biological Interactions, 118, 151–169.
   PubMed Web of Science ®Google Scholar
• JIN, C. J., MINERS, J. 0., LILLYWHITE, K. J. and MACKENZIE, P. I., 1993, Complementary deoxy-ribonucleic acid cloning and expression of a human liver uridine disphosphate-glucuronosyl-transferase glucuronidating carboxylic acid-containing drugs. Journal of Pharmacology and Experimental Therapeutics, 264, 475–479.
   Google Scholar
• KRUMDIECK, C. L., Dos SANTOS, J. E. and Ho, K. J., 1980, A new instrument for the rapid preparation of tissue slices. Analytical Biochemistry, 104, 118–123.
   PubMed Web of Science ®Google Scholar
• LUDDEN, L. K., LUDDEN, T. M., COLLINS, J. M., PENTIKIS, H. S. and STRONG, J. M., 1997, Effect of albumin on the estimation, in vitro, of phenytoin lima. and Km values: implications for clinical correlations. Journal of Pharmacology and Experimental Therapeutics, 282, 391–396.
   PubMed Web of Science ®Google Scholar
• MULDER, G. J., COUGHTRIE, M. H. W. and BURCHELL, B., 1990, Glucuronidation. In G. J. Mulder (ed.), Conjugation Reactions in Drug Metabolism (London: Taylor & Francis), pp. 51–107.
   Google Scholar
• OBACH, R. S., 1997, Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. Drug Metabolism and Disposition, 42, 1359–1369.
   Google Scholar
• OMURA, T. and SATO, R., 1962, A new cytochrome in liver microsomes. Journal of Biological Chemistry, 237, 1375–1376.
   PubMed Web of Science ®Google Scholar
• RADOMINSKA-PANDYA, A., CZERNIK, P. J. and LITTLE, J. A. 1999, Structural and functional studies of UDP-glucuronosyltransferases. Drug Metabolism Reviews, 31, 817–899.
   Google Scholar
• RETTI, A. E., WIENKERS, L. C., GONZALEZ, F. J., TRAGER, W. F. and KORZEKWA, R., 1994, Impaired (S)-warfarin metabolism catalyzed by the R144C allelic variant of CYP2C9. Pharmacokinetics, 4, 39–42.
   Google Scholar
• RITTER, J. K., CHEN, F., YHEUN, Y. S., LUBET, R. A. and OWENS, I. S., 1992, Two human liver cDNAs encode UDP-glucuronosyl transferascs with 2 log differences in activity towards parallel substrates including hyodeoxycholic acid and certain estrogen derivatives. Biochemistry, 212, 3409–3414.
   Google Scholar
• ROGAWSKI, M. A., 1992, The NMDA receptor, NMDA antagonists and epilepsy therapy. Drugs, 44, 279–292.
   PubMedGoogle Scholar
• SACCHETTI, M. L., TONI, M., FIORELLI, M., ARGENTIN°, C. and FIESCHI, C., 1997, The concept of combination therapy in acute ischemic stroke. Neurology, 49, S70–74.
   Google Scholar
• SMITH, P. C., HASEGAWA, J., LANGENDIJK, P. N. and BENET, L. Z., 1985, Stability of acyl glucuronides in blood, plasma, and urine: studies with zomepirac. Drug Metabolism and Disposition, 13, 110–112.
   PubMed Web of Science ®Google Scholar
• SPAHN-LAGGUTH, M. and BENET, L. Z., 1992, Acyl-glucuronides revisited: IS the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metabolism Reviews, 24, 5–48.
   Google Scholar
• VERONESE, M. E., MACKENZIE, P. I., DOECKE, C. J., McMANus, M. E., MINERS, J. 0. and BIRKETT, D. J., 1991, Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cyto-chrome P4502C9. Biochemical and Biophysical Research Communications, 175, 1112–1118.
   Google Scholar
• WILKINSON, G. R., 1987, Clearance approaches in pharmacology. Pharmacological Reviews, 39, 1–47.
   PubMed Web of Science ®Google Scholar